Skip to main content
. 2017 Aug 25;14(4):4625–4632. doi: 10.3892/ol.2017.6825

Figure 7.

Figure 7.

Overexpression of HOXB4 enhanced doxorubicin-mediated downregulation of cell viability in breast cancer cells. (A and B) HOXB4 mRNA and protein levels were detected in MCF-7 and MCF-7-ADR cells. (C) Cell viability was examined using the MTT assays in MCF-7-ADR cells treated with doxorubicin with or without Ad-HOXB4-CDS. (D) Cell viability of MCF-7 cells treated with doxorubicin with or without Ad-HOXB4-CDS. (E and F) Cell viability in MCF-7 and MDA-MB-231 cells with HOXB4 knockdown or overexpression, respectively. **P<0.01 vs. the control.